Animal Genetics Market - Global Forecast 2025-2032

The animal genetics market is rapidly evolving, presenting new opportunities for organizations that prioritize innovation, regulatory agility, and data-driven breeding strategies. Senior business leaders seeking to understand and lead in this industry will benefit from insights into key segmentation, technological advances, and global market dynamics that are shaping growth and competition.

Market Snapshot: Animal Genetics Market

The Animal Genetics Market grew from USD 7.17 billion in 2024 to USD 7.84 billion in 2025. It is expected to continue growing at a CAGR of 9.55%, reaching USD 14.88 billion by 2032. This robust trajectory is driven by advancements in molecular biology, precise breeding technologies, and rising demand for sustainable animal protein. Increasing regulatory adaptation and growing ethical concerns also contribute to market expansion, supporting new investments and strategic partnerships across regions.

Scope & Segmentation

This report provides a comprehensive analysis of the animal genetics sector across species, technologies, end users, and global regions. Market segmentation includes:

• Animal Types: Aquaculture, Cattle (covering both Beef and Dairy), Poultry, Swine
• Technologies: Cloning, Gene Editing (including CRISPR/Cas9, TALEN, ZFN), Genomic Selection, Marker Assisted Selection
• Applications: Disease Resistance, Feed Efficiency, Fertility, Growth Rate, Milk Production
• End Users: Academic Institutes, Commercial Breeders, Government Agencies, Pharmaceutical Companies, Research Institutes
• Regions: Americas (United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe (United Kingdom, Germany, France, Russia, Italy, Spain, Netherlands, Sweden, Poland, Switzerland), Middle East (United Arab Emirates, Saudi Arabia, Qatar, Turkey, Israel), Africa (South Africa, Nigeria, Egypt, Kenya), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan)
• Key Companies: Genus plc, Hendrix Genetics N.V., Topigs Norsvin Holding A.S., Aviagen International, Inc., Neogen Corporation, Zoetis Inc., CRV B.V., STgenetics, Inc., Genesus Inc., Lohmann Tierzucht GmbH

Key Takeaways for Senior Decision-Makers

• Genetic innovation is now a strategic driver in livestock productivity, disease management, and reducing environmental impacts.
• New gene editing modalities and bioinformatics platforms are enabling breeders to achieve performance improvements and enhance traceability across supply chains.
• Understanding diverse regulatory approaches is critical, as variation in policy adoption and approval timelines affects commercial rollout and international collaboration.
• Strategic alliances between commercial entities, academic institutions, and technology developers are accelerating the commercialization and adoption of advanced genetic tools.
• Supply chain resilience remains a key priority, especially in response to shifting trade barriers and local sourcing demands.
• End users—from pharmaceutical companies to research bodies—require tailored genetic solutions, driving differentiated value propositions and new business models.

Tariff Impact: Navigating US Policy Changes

Recent tariffs enacted by the United States in 2025 have altered the cost structure for imported genetic materials and reagents, influencing sourcing decisions industry-wide. As a result, many organizations are localizing production and diversifying partnerships to mitigate risks and ensure continued supply chain continuity. Long-term competitive strategies call for balanced international engagement alongside robust domestic innovation capacity.

Methodology & Data Sources

This report integrates primary and secondary research methods. Data are drawn from peer-reviewed scientific publications, patent registrations, regulatory records, and leading industry reports. Qualitative insights come from structured interviews with experts and surveys of market participants, delivering balanced perspectives that span geographical and operational diversity.

Why This Report Matters

• Equips decision-makers with comprehensive insights to refine R&D priorities and adapt strategies in a changing regulatory environment.
• Supports optimal resource allocation by clarifying segmentation nuances, technology adoption trends, and evolving end user requirements.
• Enables organizations to benchmark against global competitors and respond effectively to both market shifts and policy adjustments.

Conclusion

The animal genetics market is defined by fast-paced innovation, regulatory evolution, and dynamic segmentation. Strategic investment in advanced breeding solutions, combined with proactive regulatory engagement and robust supply chain planning, will enable sustained growth and lasting industry impact.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.